![Clay Siegall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clay Siegall
Verkställande Direktör på
IMMUNOME, INC.
Förmögenhet: 17 M $ per 2026-05-31
Profil
Clay B. Siegall was the founder of Seagen, Inc., founded in 1997, where the titles held included Chairman, President & Chief Executive Officer from 2004 to 2022.
Current jobs include Chairman, President & Chief Executive Officer at Immunome, Inc. since 2023; Chairman at Tourmaline Sub, Inc. since 2023; Director at Biotechnology Innovation Organization since 2012; Director at Washington Roundtable; Director at Life Science Washington; Independent Director at Shattuck Labs, Inc. since 2024; and Trustee at The Pacific Northwest Research Institute, Inc. Former jobs include President, Chief Executive Officer & Director at MorphImmune, Inc. in 2023; Chairman at Umoja Biopharma, Inc. from 2021 to 2022; Chairman at Tourmaline Bio, Inc. from 2023 to 2025; Independent Director at Ultragenyx Pharmaceutical, Inc. from 2014 to 2021; Independent Director at Nurix Therapeutics, Inc. from 2021 to 2022; Independent Director at Lundbeck Seattle BioPharmaceuticals, Inc. from 2005 to 2019; Independent Director at Mirna Therapeutics, Inc. from 2013 to 2016; and Principal Scientist at Bristol-Myers Squibb Pharmaceutical Research Institute in 1997.
Education includes a doctorate from George Washington University and an undergraduate degree from the University of Maryland.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IMMUNOME, INC. 0,61 % | 2026-03-27 | 690 704 ( 0,61 % ) | 15 M $ | 2026-05-31 |
SHATTUCK LABS, INC. 0,42 % | 2026-06-09 | 318 608 ( 0,42 % ) | 2 M $ | 2026-05-31 |
Aktiva positioner av Clay Siegall
| Företag | Position | Start |
|---|---|---|
| IMMUNOME, INC. | Verkställande Direktör | 2023-10-02 |
| SHATTUCK LABS, INC. | Direktör/Styrelseledamot | 2024-03-01 |
Washington Roundtable
 Washington Roundtable Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that comprised senior executives of major private sector employers in Washington state | Direktör/Styrelseledamot | - |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Ordförande | 2023-12-13 |
The Pacific Northwest Research Institute, Inc.
 The Pacific Northwest Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization which engages in the biomedical research | Direktör/Styrelseledamot | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktör/Styrelseledamot | 2012-12-14 |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Clay Siegall
| Företag | Position | Slut |
|---|---|---|
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Verkställande Direktör | 2023-10-01 |
| NURIX THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2022-05-15 |
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Clay Siegalls utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
62
Första gradens relationer
17
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 17 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington Roundtable
Washington Roundtable Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that comprised senior executives of major private sector employers in Washington state | Commercial Services |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Bristol-Myers Squibb Pharmaceutical Research Institute | |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Commercial Services |
The Pacific Northwest Research Institute, Inc.
The Pacific Northwest Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization which engages in the biomedical research | Commercial Services |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Health Technology |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Commercial Services |
